Evidence map›Paper›PMID 24703952›Full record

ArticleMolecular cell2014

Dephosphorylation enables the recruitment of 53BP1 to double-strand DNA breaks.

Dong-Hyun Lee, Sanket S Acharya, Mijung Kwon, Pascal Drane, Yinghua Guan, Guillaume Adelmant, Peter Kalev, Jagesh Shah, David Pellman, Jarrod A Marto and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dong-Hyun LeeDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Sciences, College of Science, Chonnam National University, Gwangju 500-757, Republic of Korea.
Sanket S AcharyaDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Mijung KwonDepartment of Cell Biology, Harvard Medical School, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA 02115, USA.
Pascal DraneDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Yinghua GuanDepartment of Systems Biology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Guillaume AdelmantDepartment of Biological Chemistry Molecular Pharmacology, Harvard Medical School, Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Peter KalevDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Jagesh ShahDepartment of Systems Biology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
David PellmanDepartment of Cell Biology, Harvard Medical School, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA 02115, USA.
Jarrod A MartoDepartment of Biological Chemistry Molecular Pharmacology, Harvard Medical School, Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Dipanjan ChowdhuryDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: dipanjan_chowdhury@dfci.harvard.edu.
Dana-Farber Cancer Institute · USHarvard University · USBrigham and Women's Hospital · US

Funding

Molecular mechanism and relevance of microRNAs in DSB repair pathway choiceR01CA142698 · NCI · DANA-FARBER CANCER INST · PI CHOWDHURY, DIPANJAN · 2010 to 2019
$3.8M
Serum microRNA as biomarker for radiation injury to lung and hematopoietic cellsR01AI101897 · NIAID · DANA-FARBER CANCER INST · PI CHOWDHURY, DIPANJAN · 2012 to 2016
$2.1M
NCI NIH HHS R01 CA142698NCI NIH HHS R01CA142698NIAID NIH HHS R01 AI101897NIAID NIH HHS R01 AI101897-01
6 · The paper itself

Abstract

Excluding 53BP1 from chromatin is required to attenuate the DNA damage response during mitosis, yet the functional relevance and regulation of this exclusion are unclear. Here we show that 53BP1 is phosphorylated during mitosis on two residues, T1609 and S1618, located in its well-conserved ubiquitination-dependent recruitment (UDR) motif. Phosphorylating these sites blocks the interaction of the UDR motif with mononuclesomes containing ubiquitinated histone H2A and impedes binding of 53BP1 to mitotic chromatin. Ectopic recruitment of 53BP1-T1609A/S1618A to mitotic DNA lesions was associated with significant mitotic defects that could be reversed by inhibiting nonhomologous end-joining. We also reveal that protein phosphatase complex PP4C/R3β dephosphorylates T1609 and S1618 to allow the recruitment of 53BP1 to chromatin in G1 phase. Our results identify key sites of 53BP1 phosphorylation during mitosis, identify the counteracting phosphatase complex that restores the potential for DDR during interphase, and establish the physiological importance of this regulation.

Indexed as

DNA Breaks, Double-StrandedProtein Processing, Post-TranslationalAmino Acid SequenceG1 PhaseHeLa CellsHumansIntracellular Signaling Peptides and ProteinsMitosisMolecular Sequence DataPhosphoprotein PhosphatasesPhosphorylationProtein BindingProtein TransportTumor Suppressor p53-Binding Protein 1Intracellular Signaling Peptides and ProteinsPhosphoprotein Phosphatasesprotein phosphatase 4TP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID24703952
PMCPMC4030556
OpenAlexW2003752349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.